WRAD complex’s impact on epigenetic regulation and immunoediting in PDAC by Francesca Citron
Wafik S. El-Deiry shared a post on X:
” Francesca Citron from MD Anderson Cancer Center speaks about WRAD complex, its interaction with the replisome, its impact on epigenetic regulation and immunoediting in PDAC.”
DPY30 regulates immunoediting by suppressing uncoordinated DNA replication in pancreatic cancer.
Authors: Francesca CitronLuigi PerelliChiara BalestrieriLuca CecchettoYanshuo ChuI-Lin HoLi ZhangEr-Yen YenLuis Castillo MontanezRutvi ShahSergio AttanasioSanjana SrinivasanCharles DykeKo-Chien ChenShan JiangJing PanSisi GaoHuamin WangWantong YaoLinghua WangMauro Di PilatoGiannicola GenoveseAndrea Viale; Giulio Draetta.
Source: Wafik S. El-Deiry/X
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023